Condition
Skin laxity
6 compounds were checked against skin laxity. None produced a gradeable row.
Last updated
Recorded under Skin ageing, alongside 2 other indications.
Recorded absences
3 compounds are listed here without a rung. Each row exists to mark a distinction a reader would otherwise draw wrongly, and each says what is missing rather than leaving the compound off the page.
-
Melanotan I
No rung — nothing on file to grade Not approved for this condition
No study has measured skin elasticity or laxity for this compound.
-
Myristoyl Pentapeptide-17
No rung — nothing on file to grade Not approved for this condition
No study has used this compound against skin laxity in humans or animals.
-
Snap-8
No rung — nothing on file to grade Not approved for this condition
No study has measured skin laxity as an outcome of acetyl octapeptide-3 alone. One multi-ingredient microneedle-patch study reported elasticity and lifting changes, but the peptide's contribution cannot be separated from the hyaluronic acid backbone, ascorbic acid glucoside and lysophosphatidic acid it was combined with.
Checked, and nothing recorded
3 compounds were checked against skin laxity and produced no gradeable row.
- Acetyl Tetrapeptide-11 — checked, no row on file
- Acetyl Tetrapeptide-5 — checked, no row on file
- Acetyl Tetrapeptide-9 — checked, no row on file
A compound is here because someone looked and the sources did not support a row — not because nobody looked. Under the rubric, uncertainty resolves to no row, and a row resting on a vendor page or a clinic blog is worse than no row at all.
What this page does not say
It reports what was measured, in whom, and how directly. It does not say what to take or at what dose, and a row here is a record of a study rather than a reason to use anything. Every rung links to the rubric that assigned it.